Inflammation in malignant mesothelioma - friend or foe?
作者信息
Linton Anthony, van Zandwijk Nico, Reid Glen, Clarke Stephen, Cao Christopher, Kao Steven
机构信息
Asbestos Diseases Research Institute, Sydney, Australia; ; University of Sydney, Sydney, Australia; ; Department of Medical Oncology, Sydney Cancer Centre, Sydney, Australia;
出版信息
Ann Cardiothorac Surg. 2012 Nov;1(4):516-22. doi: 10.3978/j.issn.2225-319X.2012.10.02.
Abstract
摘要
相似文献
1
Inflammation in malignant mesothelioma - friend or foe?恶性间皮瘤中的炎症——是友还是敌？
Ann Cardiothorac Surg. 2012 Nov;1(4):516-22. doi: 10.3978/j.issn.2225-319X.2012.10.02.
2
[Microbial "friend-foe" identification in human intestine microsymbiocenosis].[人体肠道微共生群落中微生物“敌友”识别]
Zh Mikrobiol Epidemiol Immunobiol. 2011 Nov-Dec(6):46-51.
3
FRIEND or FOE: A prospective evaluation of risk factors for reintubation in surgical and trauma patients.友敌：手术和创伤患者再次插管的风险因素的前瞻性评估。
Am J Surg. 2018 Dec;216(6):1056-1062. doi: 10.1016/j.amjsurg.2018.07.004. Epub 2018 Jul 10.
4
Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.炎症相关的 IL1β/IL1R 信号促进石棉诱导的恶性间皮瘤的发展。
Cancer Prev Res (Phila). 2016 May;9(5):406-414. doi: 10.1158/1940-6207.CAPR-15-0347. Epub 2016 Mar 2.
5
Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between "Foe" and "Friend" During Tumor Malignant Transformation.线粒体可塑性的调控改变肿瘤恶性转化过程中“敌友”之间的代谢竞争
Front Oncol. 2020 Aug 21;10:1692. doi: 10.3389/fonc.2020.01692. eCollection 2020.
6
Inflammation: friend or foe?炎症：是友还是敌？
Pharmacol Res. 2011 Feb;63(2):98. doi: 10.1016/j.phrs.2010.10.002. Epub 2010 Oct 16.
7
Cytomegalovirus infection: friend or foe in rheumatoid arthritis?巨细胞病毒感染：类风湿关节炎的敌是友？
Arthritis Res Ther. 2021 Jan 7;23(1):16. doi: 10.1186/s13075-020-02398-3.
8
γδT Cells in Lung Cancer Malignant Pleural Effusion: Friend? Foe?肺癌恶性胸腔积液中的γδT细胞：朋友还是敌人？
Am J Respir Cell Mol Biol. 2019 Aug;61(2):130-131. doi: 10.1165/rcmb.2019-0080ED.
9
Airway inflammation in COPD: friend or foe?慢性阻塞性肺疾病中的气道炎症：是友还是敌？
Am J Respir Crit Care Med. 2007 Sep 1;176(5):425-6. doi: 10.1164/rccm.200706-820ED.
10
Inflammation in surgical wound healing: friend or foe?手术伤口愈合中的炎症：是友还是敌？
Surgery. 2005 May;137(5):571-3. doi: 10.1016/j.surg.2005.01.006.
引用本文的文献
1
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.接受伊匹单抗和纳武单抗联合治疗作为一线或二线治疗的恶性胸膜间皮瘤患者的真实世界转归
JTO Clin Res Rep. 2024 Oct 15;5(12):100735. doi: 10.1016/j.jtocrr.2024.100735. eCollection 2024 Dec.
2
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort.在研究中反映间皮瘤真实世界患者情况：来自ASSESS-meso队列的基线特征中期报告。
ERJ Open Res. 2023 Dec 27;9(6). doi: 10.1183/23120541.00467-2023. eCollection 2023 Nov.
3
Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural Mesothelioma.肌肉减少症作为恶性胸膜间皮瘤手术治疗患者短期和长期预后的预测指标
Cancers (Basel). 2022 Jul 29;14(15):3699. doi: 10.3390/cancers14153699.
4
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma.免疫检查点抑制的最新进展以及（联合）阻断TIGIT作为恶性胸膜间皮瘤新策略的潜力
Biomedicines. 2022 Mar 14;10(3):673. doi: 10.3390/biomedicines10030673.
5
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma.细胞系来源的异种移植模型的代谢组学揭示了恶性间皮瘤的循环代谢特征。
PeerJ. 2022 Jan 4;10:e12568. doi: 10.7717/peerj.12568. eCollection 2022.
6
Malignant pleural mesothelioma: an update.恶性胸膜间皮瘤：最新进展。
J Bras Pneumol. 2021 Dec 13;47(6):e20210129. doi: 10.36416/1806-3756/e20210129. eCollection 2021.
7
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms.间皮瘤恶性肿瘤与微环境：分子机制
Cancers (Basel). 2021 Nov 12;13(22):5664. doi: 10.3390/cancers13225664.
8
The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review.恶性胸膜间皮瘤的免疫微环境：文献综述
Cancers (Basel). 2021 Jun 26;13(13):3205. doi: 10.3390/cancers13133205.
9
Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.恶性胸膜间皮瘤的生物标志物——关于炎症的新观点
Cancers (Basel). 2021 Feb 6;13(4):658. doi: 10.3390/cancers13040658.
10
In Silico Transcriptomic Analysis of Wound-Healing-Associated Genes in Malignant Pleural Mesothelioma.计算机转录组学分析恶性胸膜间皮瘤中与伤口愈合相关的基因。
Medicina (Kaunas). 2019 Jun 12;55(6):267. doi: 10.3390/medicina55060267.
本文引用的文献
1
Health-related quality of life and inflammatory markers in malignant pleural mesothelioma.恶性胸膜间皮瘤患者的健康相关生活质量和炎症标志物。
Support Care Cancer. 2013 Mar;21(3):697-705. doi: 10.1007/s00520-012-1569-6. Epub 2012 Aug 31.
2
Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer.中性粒细胞与淋巴细胞比值（NLR）作为 IV 期非小细胞肺癌不良预后的指标。
Clin Transl Oncol. 2012 Nov;14(11):864-9. doi: 10.1007/s12094-012-0872-5. Epub 2012 Jul 19.
3
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.中性粒细胞与淋巴细胞比值可预测癌症患者的生存情况。
Br J Cancer. 2012 Aug 7;107(4):695-9. doi: 10.1038/bjc.2012.292. Epub 2012 Jul 24.
4
New roads open up for implementing immunotherapy in mesothelioma.间皮瘤免疫治疗的实施开辟了新途径。
Clin Dev Immunol. 2012;2012:927240. doi: 10.1155/2012/927240. Epub 2012 Jun 24.
5
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis.预处理血清 C 反应蛋白水平预测恶性胸膜间皮瘤患者接受包括根治性手术在内的多模式治疗获益：一项回顾性多中心分析。
Ann Surg. 2012 Aug;256(2):357-62. doi: 10.1097/SLA.0b013e3182602af4.
6
Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.恶性胸膜间皮瘤预后因素的验证：新南威尔士尘埃疾病委员会寻求赔偿的患者数据的回顾性分析。
Clin Lung Cancer. 2013 Jan;14(1):70-7. doi: 10.1016/j.cllc.2012.03.011. Epub 2012 Jun 1.
7
Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis.石棉诱导免疫活性细胞的细胞和分子改变及其与慢性炎症和致癌作用的关系。
J Biomed Biotechnol. 2012;2012:492608. doi: 10.1155/2012/492608. Epub 2012 Feb 6.
8
C-reactive protein is associated with distant metastasis of T3 colorectal cancer.C 反应蛋白与 T3 结直肠癌的远处转移相关。
Anticancer Res. 2012 Apr;32(4):1409-15.
9
Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).探索性分析恶性胸膜间皮瘤（MPM）中 PTEN-PI3K 通路及其下游蛋白的激活情况。
Lung Cancer. 2012 Jul;77(1):192-8. doi: 10.1016/j.lungcan.2012.02.022. Epub 2012 Mar 27.
10
Inflammation-based prognostic indices in malignant pleural mesothelioma.基于炎症的恶性胸膜间皮瘤预后指标。
J Thorac Oncol. 2012 Mar;7(3):587-94. doi: 10.1097/JTO.0b013e31823f45c1.
Zotero 插件